Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Canopy Growth Corporation is a drug manufacturers-specialty & generic business based in the US. Canopy Growth Corporation shares (CGC) are listed on the NASDAQ and all prices are listed in US Dollars. Canopy Growth Corporation employs 3,259 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$14.34|
|52-week range||$12.86 - $50.92|
|50-day moving average||$14.64|
|200-day moving average||$21.21|
|Wall St. target price||$23.26|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.78|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-12)||9.22%|
|1 month (2021-09-17)||-2.52%|
|3 months (2021-07-20)||-28.12%|
|6 months (2021-04-20)||-43.90%|
|1 year (2020-10-20)||-24.05%|
|2 years (2019-10-18)||-29.05%|
|3 years (2018-10-19)||46.85|
|5 years (2016-10-20)||162.37%|
|Revenue TTM||$572.4 million|
|Gross profit TTM||$92.9 million|
|Return on assets TTM||-4.58%|
|Return on equity TTM||-24.16%|
|Market capitalisation||$5.2 billion|
TTM: trailing 12 months
There are currently 29.7 million Canopy Growth Corporation shares held short by investors – that's known as Canopy Growth Corporation's "short interest". This figure is 5% up from 28.3 million last month.
There are a few different ways that this level of interest in shorting Canopy Growth Corporation shares can be evaluated.
Canopy Growth Corporation's "short interest ratio" (SIR) is the quantity of Canopy Growth Corporation shares currently shorted divided by the average quantity of Canopy Growth Corporation shares traded daily (recently around 4.2 million). Canopy Growth Corporation's SIR currently stands at 7.02. In other words for every 100,000 Canopy Growth Corporation shares traded daily on the market, roughly 7020 shares are currently held short.
However Canopy Growth Corporation's short interest can also be evaluated against the total number of Canopy Growth Corporation shares, or, against the total number of tradable Canopy Growth Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Canopy Growth Corporation's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Canopy Growth Corporation shares in existence, roughly 80 shares are currently held short) or 0.1185% of the tradable shares (for every 100,000 tradable Canopy Growth Corporation shares, roughly 119 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Canopy Growth Corporation.
Find out more about how you can short Canopy Growth Corporation stock.
We're not expecting Canopy Growth Corporation to pay a dividend over the next 12 months.
Over the last 12 months, Canopy Growth Corporation's shares have ranged in value from as little as $12.86 up to $50.92. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Canopy Growth Corporation's is 2.1386. This would suggest that Canopy Growth Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.